The supplement forms that matter and the words that don’t

Stand in front of the magnesium shelf and count the options. Oxide, citrate, glycinate, malate, threonate, chloride. Six tubs, six prices, six confident sentences about absorption.

Some of those differences are real. Researchers have measured them in people, and the numbers are public. Others are adjectives that no federal agency defines and nobody has to prove.

Both kinds are printed in the same font, on the same label, in the same reassuring tone.

What follows sorts them into three piles: form differences that have been measured in humans, differences that are physically real but have never been tied to a health outcome, and words that appear to mean whatever the person writing the label wants them to mean.

Where the chemical form genuinely changes absorption

A mineral almost never arrives in a capsule as a bare element. It arrives bonded to a partner: an oxide, a salt, an amino acid. That partner changes how much dissolves in the stomach and how much crosses the gut wall. This part is chemistry, not copywriting, and it has been tested in people.

Magnesium

In a 1990 study from the University of Texas Southwestern Medical Center, researchers compared magnesium oxide and magnesium citrate first in the test tube and then in volunteers. Magnesium oxide was, in the paper’s description, virtually insoluble in water and only 43 percent soluble in a solution built to mimic peak stomach acid. Citrate dissolved 55 percent in plain water. After a single oral load, urinary magnesium over four hours rose far more with citrate than with oxide, 0.22 against 0.006 milligrams per milligram of creatinine. It was a small, single-dose study.

A longer British trial published in 2003 gave 46 healthy adults 300 mg of elemental magnesium daily for 60 days, as citrate, as an amino acid chelate, or as oxide, against a placebo. Both organic forms beat oxide on 24-hour urinary magnesium at 60 days. Citrate produced the highest average serum magnesium. Magnesium oxide, the cheapest and most common form on the shelf, produced no difference from placebo.

Then it gets complicated. A 2024 crossover study in 40 adults tested a microencapsulated magnesium against oxide, citrate and bisglycinate, and found no significant rise in plasma magnesium at all from bisglycinate, which is the form most heavily sold as “chelated.” Two of that paper’s five authors work for the company that owns the microencapsulation technology that won.

Two careful trials, two different verdicts on the same chelate. They measured different markers over different windows, which may explain some of the gap. Both are worth knowing, and neither cancels the other. Magnesium’s intake figures belong to article 329, which covers magnesium in full. What belongs here is that the form question for magnesium is open on at least one of its most popular forms.

Iron

The fourfold figure is the one that gets quoted. It is real, and it is much narrower than it sounds.

In a radioisotope study published in 2000, iron from ferrous bisglycinate was absorbed at a geometric mean of 6.0 percent against 1.7 percent for ferrous sulfate, about four times higher. That comparison was made in whole-maize meal porridge. Maize is high in phytate, a plant compound that binds iron and blocks its uptake. The study’s point was that the amino acid chelate resisted that blocking. In the same paper, absorption from every source tracked each subject’s own iron stores, falling as stored iron rose.

So the fourfold number describes a chelate protecting iron from a phytate-heavy meal. It does not describe a capsule swallowed with a glass of water, and nobody has shown that it transfers.

A 2014 Danish trial is closer to the question most readers have. Eighty pregnant women were randomly assigned to ferrous bisglycinate at 25 mg of iron daily or ferrous sulfate at 50 mg, from weeks 15 to 19 of pregnancy through delivery. The bisglycinate was not inferior at half the elemental dose, and stomach complaints were significantly less common in that group. Deficiency was uncommon in both arms, so the trial tested prevention in a well-nourished population, which is a narrower finding than the headline suggests. Iron’s own figures live in article 330, which covers iron in full.

Vitamin d

“D3 is better absorbed than D2” is the most repeated form claim in the category, and it needs a qualifier that almost nobody attaches.

A 2012 systematic review and meta-analysis pooled randomized trials comparing the two head to head. Vitamin D3 did raise blood 25-hydroxyvitamin D more than D2 overall. But when the authors split the trials by dosing schedule, the advantage held for large intermittent doses and, in their words, was lost with daily supplementation.

A 2022 trial in 83 Thai female health workers is often cited for D3. Look at the arms: 20,000 IU of D2 weekly against 1,000 IU of D3 daily, for 12 months. The D3 group gained more by six months, 17.6 to 26.0 nanograms per millilitre against 16.9 to 21.7. The trial changed the form and the schedule together, and the schedule is precisely the variable the meta-analysis identified as decisive. The same trial found compliance was significantly better in the weekly group.

Both sets of authors reported their results honestly. Read together, they say that for someone taking vitamin D every day, the form difference may not appear at all.

Folate

A 2020 crossover study in 24 adults compared a sodium salt of 5-methyltetrahydrofolate, the form of folate that circulates in blood, against an equivalent dose of folic acid. The methylfolate produced more than twice the plasma exposure and more than three times the peak concentration. Only folic acid produced a brief appearance of unmetabolized folic acid in the blood.

Two of that paper’s eight authors are employed by the company that manufactures the branded methylfolate salts it evaluates.

And here is the part the marketing skips. The endpoint was a blood curve over eight hours, not a health outcome. The trials that prevented neural tube defects, in 1991 and 1992, used folic acid. Weighing a blood measurement against an outcome measurement is the subject of article 326, on how to read supplement evidence.

The pattern in who paid for the finding

Four of the studies above reported an advantage for a specific form. Three of them were funded or co-authored by a company that sells the winning form.

The 2020 folate study carries two authors from the manufacturer of the methylfolate salts. The 2024 magnesium study carries two from the firm whose microencapsulation came first. A 2020 study reporting that liposomal vitamin C was 1.77 times more bioavailable than ordinary vitamin C lists an author affiliated with a liposomal supplement maker.

A fourth is unusually candid. In a 2023 liposomal multivitamin study, the authors write in the paper that the sponsor of an earlier trial commissioned their university lab to replicate it, supplied the products, and asked them to copy the original design. They present this as good science, and the argument is not empty: independent replication beats no replication. It also means the question, the design, the comparator and the capsules all traced back to one commercial source.

None of this is an accusation of fraud. It is a base rate, and somebody has measured it. Across drug and device research, industry funding tracks with more favorable published results and more favorable published conclusions, and article 326 carries the Cochrane figures. Nobody has run the same analysis on supplement trials, which is itself a gap worth knowing about.

The curcumin number that built a product category

“2,000 percent more absorbable” appears on turmeric labels everywhere. It traces to a single 1998 paper in Planta Medica, and the paper does say it.

Here is what else the paper says. The human arm gave one 2-gram dose of curcumin to a small group of volunteers. Taken alone, blood levels were, in the authors’ phrasing, either undetectable or very low. Taken with 20 mg of piperine, a black pepper compound, the Planta Medica authors wrote, “the increase in bioavailability was 2000%.”

Two thousand percent of nearly nothing is still nearly nothing. A 2,000 percent rise from an undetectable starting point can be a genuine measurement and a trivial absolute quantity at the same time. The companion rat experiment in the same paper, where baseline levels were measurable, produced a 154 percent increase. That is the figure nobody prints.

The study is 28 years old, tested a single acute dose, and carries no funding statement; an academic affiliation is listed for its first author only, so who paid cannot be determined from the paper. This article’s subject is the formulation claim; turmeric itself is article 288. The number belongs here, because it is the category’s clearest example of a true sentence doing false work.

Three words, three different kinds of meaning

Chelated has a real chemical meaning. A chelate is a mineral held inside an organic molecule, often an amino acid, in a ring-shaped grip that shields it on the way through the gut. The 2003 magnesium trial and the 2000 iron study both tested genuine amino acid chelates, and both measured real absorption differences. The word describes something.

Liposomal also describes something physical and measurable. A liposome is a microscopic fatty bubble built around the nutrient. Researchers confirm them with electron microscopy and particle sizing: the 2023 multivitamin study reported particles near 158 nanometres, and the 2020 vitamin C study reported particles under 100 nanometres with an encapsulation efficiency near 66 percent. What has not been established is the consequence. The 2023 study’s headline result, an overall treatment-by-time interaction, came in at p = 0.051, just above the 0.05 threshold the authors themselves set in their methods, with a moderate effect size. Their own conclusion states that whether long-term use affects nutrient status, function or health remains to be determined.

Activated is the odd one out. Searching the research literature and federal sources turned up no technical definition for the word as supplement labels use it. That is not proof that none exists. It does mean a shopper has nothing to check the claim against.

Then there is the asymmetry that outranks all three. No US regulation was found that defines any of these words for a supplement label. FDA states that under the 1994 law governing supplements, it does not have authority to approve dietary supplements before they are marketed. Nobody clears the adjective before it is printed. “Chelated” can be chemically accurate and still be unenforceable as a claim, which leaves the accuracy entirely to the manufacturer.

What the gummy format trades away

Gummies solve a real problem. People who cannot swallow tablets take them, and people who forget pills remember candy.

The trade is measurable. In a 2023 analysis published in JAMA, researchers tested 25 melatonin gummy products sold in the US. Twenty-two of the 25, or 88 percent, did not match their labeled melatonin content; only three landed within 10 percent of the declared amount. Measured melatonin ran from 74 percent to 347 percent of what the label said. One product contained no detectable melatonin at all, but did contain 31.3 mg of cannabidiol.

That matters because of who eats them. CDC researchers reported in 2022 that poison centers logged 260,435 pediatric melatonin ingestions between 2012 and 2021, with the annual count rising 530 percent. Melatonin accounted for 4.9 percent of all pediatric ingestions reported to poison centers in 2021, against 0.6 percent in 2012. Five children required mechanical ventilation and two died. Over the same stretch, US melatonin sales grew from $285 million in 2016 to $821 million in 2020.

There is sugar to account for as well. A 2022 crossover study in 17 adults measured a glycemic index of 81.9 for sucrose-based gummies, which is high, though the glycemic load stayed low if intake stopped below 17.2 grams. Versions sweetened with maltitol or erythritol measured 49.9 and 54.1, which is low. Six of that paper’s eight authors work for a gummy manufacturer, and its stated conclusion is that gummies are a good carrier for dietary supplements. Read the measurements, note the conclusion, and keep the two separate.

One honest gap: no peer-reviewed study of how supplement gummies degrade over their shelf life could be found in the published literature. The claim that they lose potency faster than tablets is plausible chemistry and, so far, unpublished evidence.

The form problem nobody markets

Form factor is also a safety variable, and in one group it is the dominant one. Federal emergency-department surveillance covering 2004 through 2013 found that the single largest category of supplement-related visits among adults 65 and older was not a reaction to any ingredient. It was the pill itself going down wrong, and in most of those cases the pill was a vitamin or a mineral. Article 335 carries the percentages and the rest of the age breakdown.

That is a useful signal for a specific situation. New difficulty swallowing pills, food or tablets that feel stuck, coughing during meals, or repeated choking episodes are symptoms a clinician evaluates, because they can point to problems in the throat or esophagus that have nothing to do with supplements. They are not simply a reason to buy a different format.

Whether the capsule dissolves at all

Form only matters if the thing comes apart inside you. Here is how that is governed, and it surprises most people.

Federal manufacturing rules for supplements require a company to run at least one appropriate test to verify the identity of any component that is a dietary ingredient. Finished batches are then checked against product specifications. The specifications are the manufacturer’s own. That section sets no disintegration or dissolution requirement for the finished product.

The pharmacopeial standard does exist. US Pharmacopeia General Chapter 2040, titled Disintegration and Dissolution of Dietary Supplements, lays out the tests, and USP writes that the chapter applies “where stated in the individual monographs.” That conditional clause is the whole story, because a monograph binds a product only if its maker chooses to claim conformity with it.

What that gap looks like in practice was measured in 2008, when pharmacy researchers tested 15 commercial folic acid products. They reported significant improvement over the previous decade, and still found that at least one product failed each test performed. In simulated gastric fluid, every product failed to release more than 75 percent of its active ingredient within 60 minutes. The authors attributed that largely to folic acid’s own pH-dependent solubility rather than to sloppy manufacturing, which is a fairer reading than the result alone suggests.

A voluntary verification mark is where dissolution reappears. USP’s consumer page says a product carrying its verified mark will break down and release into the body within a specified time. The seal is a private program a manufacturer applies for, not a government approval, and article 326 covers what those marks do and do not certify.

Six questions a form claim should survive

Run any “superior absorption” claim through these before it changes what you buy.

1. Measured in whom? Healthy young volunteers, or people with the condition the product is sold for?
2. Measured how? A blood level over six hours is a different kind of evidence from a health outcome over a year.
3. Measured against what? Against the weakest competing form, against placebo, or against nothing?
4. In what matrix? With a meal, with water, inside a high-phytate porridge? The iron example shows how much this moves the number.
5. On what schedule? The vitamin D example shows a form advantage that appears with intermittent dosing and disappears with daily dosing.
6. Funded by whom? Check the author affiliations and the funding statement, which are printed in the paper, not in the ad.

What the form evidence adds up to

The honest summary is split. Chemical form genuinely changes absorption for several nutrients, and the differences have been measured in real people with real numbers. Those differences are also smaller, narrower and more conditional than the labels imply, and they were frequently measured by people with a commercial stake in the answer.

The vocabulary is a different matter. “Chelated” describes a real chemistry. “Liposomal” describes a real particle. “Activated” has no definition anyone could find. None of the three is defined in US regulation for a supplement label, so none of them is a claim anyone has to stand behind.

The form may well matter. The word on the front of the bottle describing the form is not required to mean anything at all.

Sources

1. US Food and Drug Administration. “Questions and Answers on Dietary Supplements.” fda.gov
2. US Pharmacopeia. “General Chapter <2040> Disintegration and Dissolution of Dietary Supplements.” doi.usp.org
3. US Pharmacopeia. “What the USP Verified Mark Means.” usp.org
4. Electronic Code of Federal Regulations. “21 CFR 111.75 – What must you do to determine whether specifications are met?.” ecfr.gov
5. PubMed. “Lindberg JS, Zobitz MM, Poindexter JR, Pak CY. "Magnesium bioavailability from magnesium citrate and magnesium oxide." Journal of the American College of Nutrition, 1990. PubMed. DOI: 10.1080/07315724.1990.10720349.” doi.org
6. PubMed. “Walker AF, Marakis G, Christie S, Byng M. "Mg citrate found more bioavailable than other Mg preparations in a randomised, double-blind study." Magnesium Research, 2003. PubMed. PMID: 14596323.” pubmed.ncbi.nlm.nih.gov
7. PubMed. “Pajuelo D, Meissner JM, Negra T, Connolly A, Mullor JL. "Comparative Clinical Study on Magnesium Absorption and Side Effects After Oral Intake of Microencapsulated Magnesium Versus Other Magnesium Sources." Nutrients, 2024. PubMed. DOI: 10.3390/nu16244367.” doi.org
8. PubMed. “Bovell-Benjamin AC, Viteri FE, Allen LH. "Iron absorption from ferrous bisglycinate and ferric trisglycinate in whole maize is regulated by iron status." American Journal of Clinical Nutrition, 2000. PubMed. DOI: 10.1093/ajcn/71.6.1563.” doi.org
9. PubMed. “Milman N, Jonsson L, Dyre P, Pedersen PL, Larsen LG. "Ferrous bisglycinate 25 mg iron is as effective as ferrous sulfate 50 mg iron in the prophylaxis of iron deficiency and anemia during pregnancy in a randomized trial." Journal of Perinatal Medicine, 2014. PubMed. DOI: 10.1515/jpm-2013-0153.” doi.org
10. PubMed. “Tripkovic L et al. "Comparison of vitamin D2 and vitamin D3 supplementation in raising serum 25-hydroxyvitamin D status: a systematic review and meta-analysis." American Journal of Clinical Nutrition, 2012. PubMed. DOI: 10.3945/ajcn.111.031070.” doi.org
11. PubMed. “Amphansap T et al. "Efficacy of plain cholecalciferol versus ergocalciferol in raising serum vitamin D level in Thai female healthcare workers." Osteoporosis and Sarcopenia, 2022. PubMed. DOI: 10.1016/j.afos.2022.12.001.” doi.org
12. PubMed. “Obeid R et al. "Pharmacokinetics of Sodium and Calcium Salts of (6S)-5-Methyltetrahydrofolic Acid Compared to Folic Acid and Indirect Comparison of the Two Salts." Nutrients, 2020. PubMed. DOI: 10.3390/nu12123623.” doi.org
13. PubMed. “Ko J et al. "Pharmacokinetic Analyses of Liposomal and Non-Liposomal Multivitamin/Mineral Formulations." Nutrients, 2023. PubMed. DOI: 10.3390/nu15133073.” doi.org
14. PubMed. “Gopi S, Balakrishnan P. "Evaluation and clinical comparison studies on liposomal and non-liposomal ascorbic acid (vitamin C) and their enhanced bioavailability." Journal of Liposome Research, 2021. PubMed. DOI: 10.1080/08982104.2020.1820521.” doi.org
15. PubMed. “Shoba G, Joy D, Joseph T, Majeed M, Rajendran R, Srinivas PS. "Influence of piperine on the pharmacokinetics of curcumin in animals and human volunteers." Planta Medica, 1998. PubMed. DOI: 10.1055/s-2006-957450.” doi.org
16. PubMed. “Cohen PA, Avula B, Wang YH, Katragunta K, Khan I. "Quantity of Melatonin and CBD in Melatonin Gummies Sold in the US." JAMA, 2023. PubMed. DOI: 10.1001/jama.2023.2296.” doi.org
17. Centers for Disease Control and Prevention. “Lelak K, Vohra V, Neuman MI, Toce MS, Sethuraman U. "Pediatric Melatonin Ingestions – United States, 2012-2021." MMWR, 2022. PubMed. DOI: 10.15585/mmwr.mm7122a1.” doi.org
18. PubMed. “Gan D et al. "Intake of Sugar Substitute Gummy Candies Benefits the Glycemic Response in Healthy Adults: A Prospective Crossover Clinical Trial." Gels, 2022. PubMed. DOI: 10.3390/gels8100642.” doi.org
19. PubMed. “Younis IR, Stamatakis MK, Callery PS, Meyer-Stout PJ. "Influence of pH on the dissolution of folic acid supplements." International Journal of Pharmaceutics, 2008. PubMed. DOI: 10.1016/j.ijpharm.2008.09.028.” doi.org
20. PubMed. “Geller AI et al. "Emergency Department Visits for Adverse Events Related to Dietary Supplements." New England Journal of Medicine, 2015. PubMed. DOI: 10.1056/NEJMsa1504267.” doi.org
21. PubMed. “Lundh A, Lexchin J, Mintzes B, Schroll JB, Bero L. "Industry sponsorship and research outcome." Cochrane Database of Systematic Reviews, 2017. PubMed. DOI: 10.1002/14651858.MR000033.pub3.” doi.org